AVX 101

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAVX 101

Drug Alias NameSingle gene HIV vaccine - AlphaVaxAlphavirus replicon HIV-1 subtype C Gag vaccine (AVX101)AVX-101

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBotswanaUnited StatesSouth Africa

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAlphavax Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAlphavax Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

ATC CodeN/A